|Bid||33.00 x 0|
|Ask||33.22 x 0|
|Day's Range||32.47 - 34.70|
|52 Week Range||32.47 - 76.68|
|Beta (3Y Monthly)||5.27|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 27, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||56.67|
Former Canopy Growth CEO Bruce Linton discusses why he's still investing in cannabis, what he thinks is next for his former company, and his future plans. He joins Yahoo Finance's Zack Guzman and Heidi Chung to discuss.
Which stock wins in a face-off between an investment spin-off of a leading Canadian cannabis producer and the top U.S. cannabis-focused REIT?
Bruce Linton, Canopy Growth's (CGC) (WEED) former co-CEO, has acquired more stock in the company. Overall, analysts favor a “buy” rating on the stock.
Charlotte's Web has done a great job in the CBD hemp market thus far, but it may not make sense for other cannabis companies to try and follow suit.
On May 1, smokable hemp will be banned in North Carolina. The state passed the North Carolina Farm Act, removing smokable hemp from its permissible list.
Marijuana is a hot topic right now! From presidential candidates to the wealthiest Americans, everyone is talking about the sector.
Aphria stock (APHA) has surged 26.4% since the company announced its Q4 earnings results. Will Aphria's growth strategy keep paying off?
Tilray stock got a boost after the firm said its European invasion plans are to begin in Germany. Other marijuana stocks were mixed Wednesday.
On Tuesday, Jim Cramer stated that Cronos Group and Aphria passed Canopy Growth. Canopy Growth has lost 15.3% of its stock value since its Q1 earnings.
Few news items this summer jolted the legalized cannabis industry quite like the termination of former co-CEO Bruce Linton from Canopy Growth Corp.
Despite mostly equal marijuana usage rates along racial lines, the boards at the top marijuana companies are still shockingly white.
When marijuana stocks were rising, many investors got caught up in the excitement and bought large quantities at high prices. At the same time, another group of investors who paid attention to money flows made significant profits. Just like a doctor who uses X-rays to see what is going on inside the human body, investors can do X-rays of marijuana stocks.